Lin et al. (2025)
In 14 adults with mild-to-moderate periodontitis who snored and mouth-breathed, a 12-week split-mouth trial combined standard gum treatment with myTAP + Mouth Shield dual therapy. Results included significant reductions in snoring (p=0.011), mouth breathing (p=0.025), and respiratory disturbance index (p=0.019); improved gum health with less bleeding on probing and reduced Porphyromonas gingivalis (p=0.0135); and no short-term negative effects on gums or teeth—positioning the therapy as a safe adjunct that minimizes dry mouth and enhances the oral environment.